Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-13 2:50 pm Sale | 2025-06-01 | 13G | MacroGenics, Inc. MGNX | BB Biotech AG | 0 0.000% | -9,929,963 (Position Closed) | Filing History |
| 2025-05-15 3:31 pm Purchase | 2025-03-31 | 13G | MacroGenics, Inc. MGNX | Armistice Capital, LLC | 6,296,000 9.980% | 20,000 (+0.32%) | Filing History |
| 2025-04-17 4:00 pm Sale | 2025-03-31 | 13G | MacroGenics, Inc. MGNX | Millennium Management LLC | 1,724,250 2.700% | -1,485,724 (-46.28%) | Filing History |
| 2025-02-14 6:39 pm Sale | 2024-12-31 | 13G | MacroGenics, Inc. MGNX | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -4,053,077 (Position Closed) | Filing History |
| 2025-02-14 5:52 pm Purchase | 2024-12-31 | 13G | MacroGenics, Inc. MGNX | Armistice Capital, LLC | 6,276,000 9.990% | 18,000 (+0.29%) | Filing History |
| 2025-02-14 2:39 pm Unchanged | 2024-12-31 | 13G | MacroGenics, Inc. MGNX | BB Biotech AG | 9,929,963 15.800% | 0 (Unchanged) | Filing History |
| 2025-02-11 5:37 pm Purchase | 2024-12-31 | 13G | MacroGenics, Inc. MGNX | WASATCH ADVISORS LP | 3,488,493 5.600% | 1,246,131 (+55.57%) | Filing History |
| 2024-11-20 10:44 am Purchase | 2024-11-14 | 13G | MacroGenics, Inc. MGNX | Frazier Life Sciences Public Fund, L.P. | 3,175,665 5.100% | 3,175,665 (New Position) | Filing History |
| 2024-11-14 5:13 pm Purchase | 2024-09-30 | 13G | MacroGenics, Inc. MGNX | Armistice Capital, LLC | 6,258,000 9.980% | 1,686,000 (+36.88%) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | MacroGenics, Inc. MGNX | BlackRock Inc. BLK | 5,405,501 8.600% | 0 (Unchanged) | Filing History |
| 2024-10-22 3:24 pm Sale | 2024-09-30 | 13G | MacroGenics, Inc. MGNX | BlackRock Inc. BLK | 5,405,501 8.600% | -734,848 (-11.97%) | Filing History |
| 2024-06-04 4:53 pm Purchase | 2024-06-03 | 13G | MacroGenics, Inc. MGNX | Millennium Management LLC | 3,209,974 5.100% | 505,258 (+18.68%) | Filing History |
| 2024-05-21 4:12 pm Sale | 2024-05-14 | 13G | MacroGenics, Inc. MGNX | Millennium Management LLC | 2,704,716 4.300% | -102,519 (-3.65%) | Filing History |
| 2024-02-14 5:01 pm Purchase | 2023-12-31 | 13G | MacroGenics, Inc. MGNX | RA CAPITAL MANAGEMENT L.P. | 4,053,077 6.500% | 288,206 (+7.66%) | Filing History |
| 2024-02-14 2:29 pm Sale | 2023-12-31 | 13G | MacroGenics, Inc. MGNX | Armistice Capital, LLC | 4,572,000 7.370% | -1,520,000 (-24.95%) | Filing History |
| 2024-02-14 10:04 am Purchase | 2023-12-31 | 13G | MacroGenics, Inc. MGNX | T. Rowe Price Investment Management, Inc. | 5,639,994 9.100% | 5,639,994 (New Position) | Filing History |
| 2024-02-13 5:08 pm Sale | 2023-12-29 | 13G | MacroGenics, Inc. MGNX | The Vanguard Group | 4,309,394 6.950% | -134,970 (-3.04%) | Filing History |
| 2024-02-13 06:13 am Purchase | 2023-12-31 | 13G | MacroGenics, Inc. MGNX | BB Biotech AG | 9,929,963 16.000% | 1,000,000 (+11.20%) | Filing History |
| 2024-01-24 2:27 pm Purchase | 2023-12-31 | 13G | MacroGenics, Inc. MGNX | BlackRock Inc. BLK | 6,140,349 9.900% | 149,844 (+2.50%) | Filing History |
| 2023-10-30 4:45 pm Purchase | 2023-10-20 | 13G | MacroGenics, Inc. MGNX | RA CAPITAL MANAGEMENT L.P. | 3,764,871 6.100% | 3,764,871 (New Position) | Filing History |